Lorin Roskos

5.4k total citations
127 papers, 4.0k citations indexed

About

Lorin Roskos is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Oncology. According to data from OpenAlex, Lorin Roskos has authored 127 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Radiology, Nuclear Medicine and Imaging, 50 papers in Immunology and 43 papers in Oncology. Recurrent topics in Lorin Roskos's work include Monoclonal and Polyclonal Antibodies Research (54 papers), Biosimilars and Bioanalytical Methods (25 papers) and Cancer Immunotherapy and Biomarkers (17 papers). Lorin Roskos is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (54 papers), Biosimilars and Bioanalytical Methods (25 papers) and Cancer Immunotherapy and Biomarkers (17 papers). Lorin Roskos collaborates with scholars based in United States, United Kingdom and Australia. Lorin Roskos's co-authors include Mohammad Tabrizi, Gisela Schwab, Bingbing Yang, Rajesh Narwal, G Schwab, Paolo Vicini, Meina Liang, Manoj Bajpai, Dongbei Shen and R H Lévy and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Lorin Roskos

121 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorin Roskos United States 34 1.5k 1.1k 1.0k 1.0k 478 127 4.0k
André Rogatko United States 43 2.6k 1.7× 457 0.4× 1.9k 1.8× 551 0.5× 1.0k 2.2× 170 6.2k
Fritz Offner Belgium 40 2.3k 1.5× 515 0.5× 1.3k 1.3× 1.1k 1.1× 546 1.1× 236 6.1k
Ann T. Farrell United States 37 2.5k 1.7× 428 0.4× 2.8k 2.7× 936 0.9× 621 1.3× 75 6.7k
Joseph M. Tuscano United States 34 1.3k 0.9× 507 0.5× 1.1k 1.1× 932 0.9× 284 0.6× 150 4.3k
Yoichi Imai Japan 41 1.1k 0.7× 385 0.4× 2.6k 2.5× 871 0.9× 620 1.3× 189 5.5k
Junji Uchida Japan 36 2.2k 1.4× 657 0.6× 1.3k 1.2× 1.4k 1.4× 1.8k 3.9× 251 6.4k
Christoph A. Ritter Germany 29 2.4k 1.6× 730 0.7× 2.0k 2.0× 288 0.3× 628 1.3× 83 4.3k
Liping Du China 34 581 0.4× 208 0.2× 897 0.9× 452 0.4× 498 1.0× 172 4.0k
Mourad Tighiouart United States 38 1.7k 1.2× 311 0.3× 1.6k 1.6× 276 0.3× 930 1.9× 152 5.0k
Olivier Rosmorduc France 43 2.4k 1.6× 435 0.4× 1.3k 1.2× 406 0.4× 1.4k 3.0× 129 8.0k

Countries citing papers authored by Lorin Roskos

Since Specialization
Citations

This map shows the geographic impact of Lorin Roskos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorin Roskos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorin Roskos more than expected).

Fields of papers citing papers by Lorin Roskos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorin Roskos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorin Roskos. The network helps show where Lorin Roskos may publish in the future.

Co-authorship network of co-authors of Lorin Roskos

This figure shows the co-authorship network connecting the top 25 collaborators of Lorin Roskos. A scholar is included among the top collaborators of Lorin Roskos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorin Roskos. Lorin Roskos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mou, Si, B. Timothy Hummer, Jiaqi Yuan, et al.. (2025). Investigations of Enteric-Coated Tablet Propyl Gallate-Induced Nephrotoxicity in Beagles as well as Human and Dog Renal Proximal Tubule Epithelial Cells. ACS Pharmacology & Translational Science. 8(5). 1282–1291.
2.
3.
4.
Zhang, Jianchun, Robert Kubiak, Lorin Roskos, et al.. (2020). A new method for identification of outliers in immunogenicity assay cut point data. Journal of Immunological Methods. 484-485. 112817–112817. 10 indexed citations
5.
Wang, Hanwen, Oleg Milberg, Imke H. Bartelink, et al.. (2019). In silico simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model. Royal Society Open Science. 6(5). 190366–190366. 51 indexed citations
6.
Kijanka, Grzegorz, Jared S. Bee, Yuling Wu, et al.. (2018). Submicron Size Particles of a Murine Monoclonal Antibody Are More Immunogenic Than Soluble Oligomers or Micron Size Particles Upon Subcutaneous Administration in Mice. Journal of Pharmaceutical Sciences. 107(11). 2847–2859. 56 indexed citations
7.
D’Angelo, Gina, Raghothama Chaerkady, Wen Yu, et al.. (2017). Statistical Models for the Analysis of Isobaric Tags Multiplexed Quantitative Proteomics. Journal of Proteome Research. 16(9). 3124–3136. 25 indexed citations
8.
Zhang, Jianchun, Wenjia Li, Lorin Roskos, & Harry Yang. (2017). Immunogenicity assay cut point determination using nonparametric tolerance limit. Journal of Immunological Methods. 442. 29–34. 11 indexed citations
9.
Zhang, Jianchun, Binbing Yu, Lanju Zhang, et al.. (2014). Non-Normal Random Effects Models for Immunogenicity Assay Cut Point Determination. Journal of Biopharmaceutical Statistics. 25(2). 295–306. 9 indexed citations
10.
Vainshtein, Inna, Lorin Roskos, Jackie Cheng, et al.. (2014). Quantitative Measurement of the Target-Mediated Internalization Kinetics of Biopharmaceuticals. Pharmaceutical Research. 32(1). 286–299. 26 indexed citations
11.
Narwal, Rajesh, Lorin Roskos, & Gabriel J. Robbie. (2013). Population Pharmacokinetics of Sifalimumab, an Investigational Anti-Interferon-α Monoclonal Antibody, in Systemic Lupus Erythematosus. Clinical Pharmacokinetics. 52(11). 1017–1027. 22 indexed citations
12.
Schwickart, Martin, Jennifer Pearson, Carlos Chávez, et al.. (2013). Identification and elimination of target-related matrix interference in a neutralizing anti-drug antibody assay. Journal of Immunological Methods. 403(1-2). 52–61. 9 indexed citations
13.
Wang, Bing, Meina Liang, Zhenling Yao, et al.. (2012). Pharmacokinetic and Pharmacodynamic Comparability Study of Moxetumomab Pasudotox, an Immunotoxin Targeting CD22, in Cynomolgus Monkeys. Journal of Pharmaceutical Sciences. 102(1). 250–261. 8 indexed citations
14.
Wang, Bing, Yvonne Lau, Meina Liang, et al.. (2011). Mechanistic Modeling of Antigen Sink Effect for Mavrilimumab Following Intravenous Administration in Patients With Rheumatoid Arthritis. The Journal of Clinical Pharmacology. 52(8). 1150–1161. 24 indexed citations
15.
Tabrizi, Mohammad, Bing Wang, Hong Lü, et al.. (2010). Population Pharmacokinetic Evaluation of a Fully Human IgG2 Monoclonal Antibody in Patients with Inflammatory Diseases. Inflammation & Allergy - Drug Targets. 9(4). 229–237. 13 indexed citations
16.
Tabrizi, Mohammad, Gadi Gazit Bornstein, Scott L. Klakamp, et al.. (2009). Translational strategies for development of monoclonal antibodies from discovery to the clinic. Drug Discovery Today. 14(5-6). 298–305. 23 indexed citations
17.
Liang, Meina, Scott L. Klakamp, Hong Lü, et al.. (2007). Detection of High- and Low-Affinity Antibodies Against a Human Monoclonal Antibody Using Various Technology Platforms. Assay and Drug Development Technologies. 5(5). 655–662. 66 indexed citations
18.
Jakobovits, Aya, Rafael G. Amado, Xiaodong Yang, Lorin Roskos, & Gisela Schwab. (2007). From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic mice. Nature Biotechnology. 25(10). 1134–1143. 153 indexed citations
19.
Wang, Bing, et al.. (2001). Population Pharmacokinetic–Pharmacodynamic Modeling of Filgrastim (r-metHuG-CSF) in Healthy Volunteers. Journal of Pharmacokinetics and Pharmacodynamics. 28(4). 321–342. 44 indexed citations
20.
Boer, Richard H. De, Lorin Roskos, Ellen Cheung, et al.. (2000). Pharmacokinetic Analysis of Pegylated Megakaryocyte Growth and Development Factor in Humans. Growth Factors. 18(3). 215–226. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by André Rogatko Breakdown of academic impact, for papers by Fritz Offner Breakdown of academic impact, for papers by Ann T. Farrell Breakdown of academic impact, for papers by Joseph M. Tuscano Breakdown of academic impact, for papers by Yoichi Imai Breakdown of academic impact, for papers by Junji Uchida Breakdown of academic impact, for papers by Christoph A. Ritter Breakdown of academic impact, for papers by Liping Du Breakdown of academic impact, for papers by Mourad Tighiouart Breakdown of academic impact, for papers by Olivier Rosmorduc
Rankless by CCL
2026